August 2025

Early Cancer Detection: Methods, Benefits, and Screening Options

Aug 28, 2025 | Insights

By Dr. Letizia Gulino, PhD Head of Science & Technology, RMDM Group Dr. Letizia Gulino is the Head of Science and Technology at RMDM Group, bringing over 20 years of extensive experience in molecular medicine research and private sector innovation. Holding a PhD...

Independent Validation of Apo10 and TKTL1 Biomarkers Strengthens PanTum Detect’s Scientific Foundation

Aug 19, 2025 | News, Diagnostics Activity

A recently published study in BMC Medicine provides strong, independent evidence supporting the clinical utility of the EDIM-based biomarkers Apo10 and TKTL1 for the early detection of cervical cancer. These are the same two biomarkers at the heart of RMDM’s PanTum...

Changing Preventative Care in the Middle East

Aug 15, 2025 | News, Diagnostics Activity

Preventative Care in the Middle East: A New Era Begins Preventative healthcare in the Middle East is undergoing a significant transformation. With chronic diseases on the rise and late-stage diagnoses still far too common, the introduction of innovative diagnostics,...

Early Cancer Detection: Methods, Benefits, and Screening Options

Independent Validation of Apo10 and TKTL1 Biomarkers Strengthens PanTum Detect’s Scientific Foundation

Changing Preventative Care in the Middle East

Archives

Let’s Stay Connected

Sign Up To Our Newsletter And Stay Up To Date With The Latest News From RMDM